Your browser doesn't support javascript.
Genome-wide screening identifies DNA methylation sites that regulate the blood proteome.
Nikpay, Majid; Ravati, Sepehr; McPherson, Ruth.
  • Nikpay M; Omics and Biomedical Analysis Core Facility, University of Ottawa Heart Institute, Ottawa, K1Y 4W7, Canada.
  • Ravati S; Plastenor Technologies Company, Montreal, H2P 2G4, Canada.
  • McPherson R; Omics and Biomedical Analysis Core Facility, University of Ottawa Heart Institute, Ottawa, K1Y 4W7, Canada.
Epigenomics ; 2022 Jul 19.
Article in English | MEDLINE | ID: covidwho-1952090
ABSTRACT

Background:

Identifying DNA methylation sites that regulate the blood proteome is important for biomedical purposes. Materials &

methods:

Here the authors performed a genome-wide search to find DNA methylation sites that impact proteins.

Results:

 The authors identified 165 methylation sites associated with 138 proteins. The authors noted hotspot genomic regions that control the levels of several proteins. For example, methylation of the ABO locus impacted 37 proteins and contributed to cardiometabolic comorbidities, including the severity of SARS-CoV-2 infection. The authors made these findings publicly available as a Unix software that identifies methylation sites that cause disease and reveals the underlying proteins. The authors underlined the software application by showing that components of innate immunity contribute to systolic blood pressure.

Conclusion:

This study provides a catalog of DNA methylation sites that regulate the proteome, and the results are available as freeware for biological insight.
Our lifestyle choices and interactions with the world around us are continuously printed in our DNA through a biochemical process known as epigenomic modification. Excessive epigenomic modification at a DNA site may cause disease. To prevent or treat disease, it is important to find such sites and remove the excessive epigenomic modification with medications or lifestyle changes. Here the authors searched for DNA sites that undergo epigenomic modification. The authors also investigated the mechanism whereby these sites cause disease. The authors found that there are DNA sites where reverting the epigenomic modification could have a big impact on the body. The authors have made these findings publicly available.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Epi-2022-0119

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Epi-2022-0119